Cutia Therapeutics (HKG:2487)

Cutia Therapeutics Statistics

Total Valuation

HKG:2487 has a market cap or net worth of HKD 1.67 billion. The enterprise value is 1.15 billion.

Market Cap	1.67B
Enterprise Value	1.15B

Important Dates

The next estimated earnings date is Thursday, May 28, 2026.

Earnings Date	May 28, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2487 has 363.37 million shares outstanding. The number of shares has increased by 7.70% in one year.

Current Share Class	363.37M
Shares Outstanding	363.37M
Shares Change (YoY)	+7.70%
Shares Change (QoQ)	+7.58%
Owned by Insiders (%)	5.89%
Owned by Institutions (%)	6.55%
Float	97.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.47
PB Ratio	1.70
P/TBV Ratio	1.71
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.03
EV / Sales	3.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.42

Financial Position

The company has a current ratio of 3.87, with a Debt / Equity ratio of 0.36.

Current Ratio	3.87
Quick Ratio	3.67
Debt / Equity	0.36
Debt / EBITDA	n/a
Debt / FCF	-1.05
Interest Coverage	-31.78

Financial Efficiency

Return on equity (ROE) is -36.58% and return on invested capital (ROIC) is -15.44%.

Return on Equity (ROE)	-36.58%
Return on Assets (ROA)	-14.29%
Return on Invested Capital (ROIC)	-15.44%
Return on Capital Employed (ROCE)	-29.77%
Weighted Average Cost of Capital (WACC)	6.23%
Revenue Per Employee	1.23M
Profits Per Employee	-1.25M
Employee Count	304
Asset Turnover	0.25
Inventory Turnover	2.55

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.93% in the last 52 weeks. The beta is 0.51, so HKG:2487's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	-25.93%
50-Day Moving Average	4.71
200-Day Moving Average	6.73
Relative Strength Index (RSI)	44.68
Average Volume (20 Days)	194,160

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2487 had revenue of HKD 374.07 million and -378.57 million in losses. Loss per share was -1.14.

Revenue	374.07M
Gross Profit	217.88M
Operating Income	-343.42M
Pretax Income	-378.57M
Net Income	-378.57M
EBITDA	-309.28M
EBIT	-343.42M
Loss Per Share	-1.14

Balance Sheet

The company has 877.16 million in cash and 353.20 million in debt, with a net cash position of 523.97 million or 1.44 per share.

Cash & Cash Equivalents	877.16M
Total Debt	353.20M
Net Cash	523.97M
Net Cash Per Share	1.44
Equity (Book Value)	985.15M
Book Value Per Share	2.71
Working Capital	860.13M

Cash Flow

In the last 12 months, operating cash flow was -322.82 million and capital expenditures -13.01 million, giving a free cash flow of -335.83 million.

Operating Cash Flow	-322.82M
Capital Expenditures	-13.01M
Depreciation & Amortization	35.33M
Net Borrowing	-21.74M
Free Cash Flow	-335.83M
FCF Per Share	-0.92

Margins

Gross margin is 58.25%, with operating and profit margins of -91.81% and -101.20%.

Gross Margin	58.25%
Operating Margin	-91.81%
Pretax Margin	-101.20%
Profit Margin	-101.20%
EBITDA Margin	-82.68%
EBIT Margin	-91.81%
FCF Margin	n/a

Dividends & Yields

HKG:2487 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.70%
Shareholder Yield	-7.70%
Earnings Yield	-22.65%
FCF Yield	-20.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2487 has an Altman Z-Score of -0.61 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.61
Piotroski F-Score	4